Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Other Accumulated Expenses (2021 - 2022)

Historic Other Accumulated Expenses for Regenerative Medical Technology (RMTG) over the last 2 years, with Q1 2022 value amounting to $10000.0.

  • Regenerative Medical Technology's Other Accumulated Expenses changed N/A to $10000.0 in Q1 2022 from the same period last year, while for Mar 2022 it was $10000.0, marking a year-over-year change of. This contributed to the annual value of $20000.0 for FY2021, which is N/A changed from last year.
  • Regenerative Medical Technology's Other Accumulated Expenses amounted to $10000.0 in Q1 2022.
  • In the past 5 years, Regenerative Medical Technology's Other Accumulated Expenses registered a high of $251536.0 during Q3 2021, and its lowest value of $10000.0 during Q1 2022.